Confidence. It comes from knowing that you have the right partner for IVDR compliance.
Test portfolio on track to be converted to IVDR
In Vitro Diagnostic Regulation (IVDR – 2017/746) is the current regulatory basis for placing on the market, making available, and putting into service in vitro diagnostic medical devices in the European market.1 IVDR replaces the previous regulation, the In Vitro Diagnostic Directive (IVDD – 98/79/EC).
IVDR – 2017/746 was published in the Official Journal of the EU on 5 May 2017 and entered into force on 26 May 2017. As a European regulation, it is currently effective in all EU member states and EEA states.
The new regulations aim to ensure the effectiveness and safety of medical device marketing within the EU. Cepheid is diligently working to ensure all relevant products are covered under the new ordinance.
Any in vitro diagnostic medical device considered a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, piece of equipment, software, or accessory, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally to provide information on one or more of the following:
Cepheid is working to ensure all relevant products are IVDR-compliant and have processes in place for recertification to ensure product continuity for all our customers.
For most products, changes will be minimal: same product code, same performance, and validation requirements will be kept to a minimum. For a few products, there will be a change in catalog number, which may entail more extensive update/validation processes.
Changes may include but not limited to:
Before a product is launched, all users will receive a letter detailing these changes and Cepheid's teams will be mobilized to help make this changeover as smooth as possible.
Enhanced Traceability and Transparency with IVDR
A sophisticated EU database for medical devices—EUDAMED
Review our IVDR-compliant Cepheid products on the official EUDAMED database
Certain information on devices and device's performance will be made public (e.g. summary of safety and performance (SSP)) within EUDAMED
Unique Device Identifier (UDI) to ensure traceability in the supply chain
Cepheid is on Track to Finalize IVDR Certification
and implement all requirements for Xpert® tests and the GeneXpert® systems.
IVDR Compliance for the GeneXpert Systems and Collection Devices
Xpert® Tests on Track To Be IVDR Certified
Cepheid shares the values of transparency and health protection for patients and users championed by the IVDR and is committed to supporting all our customers and distributors during this transition phase.
Test Portfolio on Track To Be Converted To IVDR
DMDIV. Dispositif médical de diagnostic in vitro. Peut être indisponible dans certains pays
1. In vitro Diagnostic Medical Device Regulation (IVDR). (2021). TUV. https://www.tuvsud.com/en-us/industries/healthcare-and-medical-devices/medical-devices-and-ivd/medical-device-market-approval-and-certification/eu-in-vitro-diagnostic-medical-device-regulation/faqs-in-vitro-diagnostic-medical-device-regulation-ivdr
2. Regulation (Eu) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU
3. https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32017R0746&from=EN